Paclitaxel shows cytotoxic activity in human hepatocellular carcinoma cell lines
- 1 February 1999
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 136 (1) , 109-118
- https://doi.org/10.1016/s0304-3835(98)00388-7
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- UCN-01: a Potent Abrogator of G2 Checkpoint Function in Cancer Cells With Disrupted p53JNCI Journal of the National Cancer Institute, 1996
- Paclitaxel-induced apoptosis in human gastric carcinoma cell linesCancer, 1996
- Characterization of the Taxol Binding Site on the MicrotubuleJournal of Biological Chemistry, 1995
- Cyclins, Cyclin-Dependent Kinases and Cdk Inhibitors: Implications in Cell Cycle Control and CancerCritical Reviews™ in Eukaryotic Gene Expression, 1995
- Comparison of paclitaxel and docetaxel (Taxotere) in gynecologic and breast cancer cell lines with the ATP–cell viability assayAnti-Cancer Drugs, 1994
- Detection of p53 gene mutations in rat hepatocellular carcinoma cell lines by denaturing gradient gel electrophoresisMolecular Carcinogenesis, 1993
- Mitogenic effects of hepatic stimulator substance on cultured nonparenchymal liver epithelial cellsHepatology, 1992
- p53 mutations are absent from carcinogen‐induced mouse liver tumors but occur in cell lines established from these tumorsMolecular Carcinogenesis, 1992
- Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell lineNature, 1979
- Promotion of microtubule assembly in vitro by taxolNature, 1979